1. Home
  2. EVOK

EVOK

Evoke Pharma Inc.

Logo Evoke Pharma Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Founded: 2007 Country:
United States
United States
Employees: N/A City: SOLANA BEACH
Market Cap: 4.0M IPO Year: 2013
Target Price: N/A AVG Volume (30 days): 47.4K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.33 EPS Growth: N/A
52 Week Low/High: $0.50 - $2.42 Next Earning Date: 05-13-2024
Revenue: $5,180,630 Revenue Growth: 106.51%
Revenue Growth (this year): 177.24% Revenue Growth (next year): 55.55%

Share on Social Networks: